BFSG LLC’s Microbot Medical MBOT Stock Holding History

BFSG LLC’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7K	Hold	5,500	–	–	﹤0.01%	572
2026 Q1	$13.3K	Hold	5,500	–	–	﹤0.01%	536
2025 Q4	$11K	Hold	5,500	–	–	﹤0.01%	535
2025 Q3	$16.8K	Hold	5,500	–	–	﹤0.01%	492
2025 Q2	$13.9K	Hold	5,500	–	–	﹤0.01%	488
2025 Q1	$8.3K	Hold	5,500	–	–	﹤0.01%	517
2024 Q4	$6.16K	Hold	5,500	–	–	﹤0.01%	547
2024 Q3	$4.92K	Hold	5,500	–	–	﹤0.01%	544
2024 Q2	$5.61K	Buy	5,500 +4,500	+450%	+$4.63K	﹤0.01%	519
2024 Q1	$1.23K	Buy	+1,000	New	+$1.27K	﹤0.01%	610

Other funds holding MBOT

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

BFSG LLC's MBOT Position: Q2 2026 in Review

BFSG LLC held its Microbot Medical (MBOT) position steady in Q2 2026 at 5,500 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

BFSG LLC first reported a position in MBOT in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.8K in Q3 2025. 4 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

BFSG LLC held 5,500 shares of Microbot Medical worth $10.7K as of Q2 2026.
BFSG LLC left its Microbot Medical share count unchanged in Q2 2026.
Microbot Medical made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #572 holding.
BFSG LLC first reported a position in Microbot Medical in Q1 2024 and has held it in 10 quarters since.
BFSG LLC's Microbot Medical position peaked at $16.8K in Q3 2025.
4 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.